$0.13
3.85%
Downside
Day's Volatility :3.85%
Upside
0.0%
7.69%
Downside
52 Weeks Volatility :47.48%
Upside
43.11%
Period | Zomedica Corp | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | -14.61% | 5.1% | 0.0% |
6 Months | -8.12% | 4.9% | 0.0% |
1 Year | -29.83% | 16.6% | 0.0% |
3 Years | -78.25% | 13.2% | -22.3% |
Market Capitalization | 127.4M |
Book Value | $0.21 |
Earnings Per Share (EPS) | -0.06 |
Wall Street Target Price | 0.44 |
Profit Margin | -214.7% |
Operating Margin TTM | -147.5% |
Return On Assets TTM | -9.29% |
Return On Equity TTM | -23.92% |
Revenue TTM | 26.1M |
Revenue Per Share TTM | 0.03 |
Quarterly Revenue Growth YOY | 1.7999999999999998% |
Gross Profit TTM | 13.7M |
EBITDA | -29.4M |
Diluted Eps TTM | -0.06 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 238.46%
Sell
Neutral
Buy
Zomedica Corp is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Zomedica Corp | -13.8% | -8.12% | -29.83% | -78.25% | -70.8% |
![]() Stryker Corporation | 12.3% | 0.36% | 24.19% | 28.8% | 65.26% |
![]() Boston Scientific Corp. | 10.6% | 20.32% | 51.42% | 80.93% | 95.5% |
![]() Edwards Lifesciences Corp. | 9.4% | -28.78% | -12.2% | -45.23% | -7.73% |
![]() Abbott Laboratories | 3.57% | -5.84% | 13.1% | -11.32% | 35.19% |
![]() Medtronic Plc | 10.85% | 5.57% | 12.46% | -33.2% | -16.71% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Zomedica Corp | NA | NA | NA | 0.0 | -0.24 | -0.09 | NA | 0.21 |
![]() Stryker Corporation | 39.84 | 39.84 | 2.64 | 12.0 | 0.19 | 0.07 | 0.01 | 51.86 |
![]() Boston Scientific Corp. | 66.34 | 66.34 | 2.01 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
![]() Edwards Lifesciences Corp. | 26.3 | 26.3 | 3.2 | 2.69 | 0.22 | 0.12 | NA | 12.35 |
![]() Abbott Laboratories | 35.92 | 35.92 | 4.16 | 4.66 | 0.14 | 0.06 | 0.02 | 22.6 |
![]() Medtronic Plc | 30.16 | 30.16 | 1.66 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Zomedica Corp | Sell | $127.4M | -70.8% | NA | -214.7% |
![]() Stryker Corporation | Buy | $136.8B | 65.26% | 39.84 | 16.12% |
![]() Boston Scientific Corp. | Buy | $120.2B | 95.5% | 66.34 | 12.0% |
![]() Edwards Lifesciences Corp. | Buy | $40.2B | -7.73% | 26.3 | 23.74% |
![]() Abbott Laboratories | Buy | $198.1B | 35.19% | 35.92 | 13.65% |
![]() Medtronic Plc | Buy | $115.3B | -16.71% | 30.16 | 12.06% |
Insights on Zomedica Corp
Revenue is down for the last 3 quarters, 7.33M → 6.13M (in $), with an average decrease of 8.4% per quarter
Netprofit is down for the last 2 quarters, -9.16M → -23.93M (in $), with an average decrease of 161.3% per quarter
In the last 1 year, Boston Scientific Corp. has given 51.4% return, outperforming this stock by 81.2%
In the last 3 years, Boston Scientific Corp. has given 80.9% return, outperforming this stock by 159.2%
zomedica (nyse american:zom) (tsx-v:zom) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. with a team that includes clinical veterinary professionals, it is zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care.
Organization | Zomedica Corp |
Employees | 144 |
CEO | Mr. Larry C. Heaton II |
Industry | Health Technology |
A Spac I Acquisition Corp
$0.13
-0.7%
Keyarch Acquisition Corp
$0.13
-0.7%
Connexa Sports Technologies Inc
$0.13
-0.7%
Us Value Etf
$0.13
-0.7%
First Wave Biopharma Inc
$0.13
-0.7%
Global X Msci Next Emerging
$0.13
-0.7%
Fat Projects Acquisition Corp
$0.13
-0.7%
Capital Link Global Fintech
$0.13
-0.7%
Applied Uv Inc
$0.13
-0.7%